Leaflet CEREBROLYSIN 215.2mg / ml solution for injection / concentrate for solution for infusion

Indicated for: cognitive disorders; cerebral metabolic support

Route of administration: injectable / infusion

Substance: hydrolyzed protein from porcine brain (cerebral metabolic agent)

ATC: N07XXN3 (Nervous system | Other nervous system drugs)

Porcine brain protein hydrolysate is a biological extract used in the treatment of neurological and cognitive disorders. It contains peptides and amino acids that support the functioning of the central nervous system, improving memory, concentration, and neuronal regeneration. It is commercially known as Cerebrolysin.

This hydrolysate works by stimulating neuronal metabolism, protecting nerve cells from oxidative stress and damage. It also promotes the regeneration of axons and synapses, making it useful in conditions such as stroke, dementia, Alzheimer’s disease, traumatic brain injuries, and other neurodegenerative disorders.

The medication is administered as intravenous or intramuscular injections, typically in courses of 10-20 days, depending on the severity of the condition and the doctor’s recommendations. The dosage and duration of treatment are adjusted based on the patient’s response.

Side effects are rare but may include injection site reactions, dizziness, nausea, insomnia, or agitation. In very rare cases, severe allergic reactions may occur. It is important for patients to inform their doctor of any adverse reactions and to strictly follow medical instructions.

Porcine brain protein hydrolysate is contraindicated in patients with allergies to its components, severe epilepsy, or severe renal impairment. Treatment should be conducted under the supervision of a specialist, and long-term use should be carefully evaluated.